Fri.Nov 18, 2022

Extra Hot Nanoparticles for Cancer Therapy

Medgadget

Researchers at Oregon State University created a new type of hyperthermic magnetic nanoparticle that is intended to assist in destroying tumors through localized heating under an alternating magnetic field.

Ultimate Door to Door Sales Guide (With Tips & Scripts)

Spotio

Looking to level-up your door to door sales process in 2022? This guide is for you. Let’s be honest. There is a stigma around door to door sales and that it’s an antiquated way of selling.

Sun Pharma- Walk In Interviews for B.Sc / B.Pharm/  Diploma/ ITI/ B.E in Production/ Engineering Dept. On 20th Nov’ 2022

Pharma Pathway

Sun Pharma- Walk In Interviews for B.Sc / B.Pharm/ Diploma/ ITI/ B.E in Production/ Engineering Dept. On 20th Nov’ 2022. Job Description. Walk-In Interviews for Female Candidates. Department: Production/ Engineering. Division: Technician/ Officer/ Senior Officer.

Ferrobot Swarms for Rapid Viral Testing

Medgadget

At the University of California Los Angeles, scientists have developed a handheld lab kit that can conduct automated pooled testing for viral diseases, including COVID-19.

Jubilant Biosys Limited- Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022

Pharma Pathway

Jubilant Biosys Limited- Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022. Job Description. Walk-In Drive for Freshers & Experienced On 20th Nov’ 2022 @ Jubilant Biosys Limited. Walk-In Drive @ Jubilant Biosys Limited.

In Arkansas and Michigan, Voters “Defund” Public Libraries

Copyright Clearance Center

The post In Arkansas and Michigan, Voters “Defund” Public Libraries appeared first on Copyright Clearance Center. CCC in the News

77

More Trending

MHRA approves first gene therapy for infusion into the brain

European Pharmaceutical Review

Upstaza (eladocagene exuparvovec) is the first and only approved treatment for aromatic L-amino acid decarboxylase (AADC) deficiency and is the first marketed gene therapy for direct infusion into the brain.

Provention Wins FDA Approval for First Drug to Delay Type 1 Diabetes Progression

MedCity News

Type 1 diabetes patients now have a new therapeutic option for the autoimmune disorder. Provention Bio drug Tzeild has received FDA approval for delaying the onset of the most severe stage of this chronic disease.

FDA 101

Hybrid work is here to stay — here’s how leaders should adjust

PharmaVoice

Executives across the life sciences share their tips for navigating the new norm of remote work

69

With Its New, Outsourced Virtual Care Model, Will the Third Time Be the Charm for Amazon?

MedCity News

Instead of building its own network of providers and bringing hybrid care services to employers like it did with Amazon Care, the new Amazon Clinic model is direct-to-consumer and outsources to third-party providers.

Retail 101

Apellis' closely watched eye drug gets new FDA goal date after changes to its filing scared investors

Fierce Pharma

Apellis' closely watched eye drug gets new FDA goal date after changes to its filing scared investors. Fri, 11/18/2022 - 11:21

Kaiser Nurses Avert Strike and Get 22.5% Raise With New Contract

MedCity News

About 22,000 nurses and nurse practitioners reached a tentative agreement with Kaiser Permanente,, averting what would have been the biggest private sector nurses strike in American history.

99

With Sanofi as its marketing partner, Provention Bio grabs long-awaited FDA nod for diabetes drug

Fierce Pharma

With Sanofi as its marketing partner, Provention Bio grabs long-awaited FDA nod for diabetes drug. kdunleavy. Fri, 11/18/2022 - 10:21

Non-profit sues FDA, requesting the agency withdraw approval for abortion drugs

MedCity News

The group complains that the FDA never studied the safety of the drugs under the labeled conditions of use. . Daily News SYN Top Story abortion drugs FDA mifepristone misoprostol U.S. Food and Drug Administration

Regeneron, CytomX announce bispecific therapeutics for cancer collab

Pharma Phorum

Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc. have announced a strategic research collaboration within the field of conditionally activated bispecific therapeutics for the treatment of cancer.

The Impending Shift in the Delivery of Cardiac Care Creates Opportunities for Physicians and Hospitals

MedCity News

The shifting of services to outpatient settings will likely cause hospitals to unwind their contractual relationships with cardiologists, sending the physicians back into private practice.

US FDA approves Provention Bio’s Tzield to delay diabetes

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved Provention Bio’s biologics licence application (BLA) for Tzield (teplizumab-mzwv) to treat type 1 diabetes (T1D) patients.

Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim

Fierce Pharma

Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim. fkansteiner. Fri, 11/18/2022 - 11:01

Results gap between digital leaders and laggards

Pharma Phorum

Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity.

Clarivate releases Annual G20 Scorecard of research performance for 2022

Clarivate

To coincide with the 17th G20 Heads of State and Government Summit taking place in Bali, Clarivate has released its Annual G20 Scorecard – Research Performance 2022. .

Fierce Pharma Asia—BioNTech, GSK grow in Singapore; Astellas' stomach cancer win; Daiichi's mRNA vaccine readout

Fierce Pharma

Fierce Pharma Asia—BioNTech, GSK grow in Singapore; Astellas' stomach cancer win; Daiichi's mRNA vaccine readout. Fri, 11/18/2022 - 09:44

Takeda’s Iclusig bests imatinib in first-line leukaemia trial

Pharma Phorum

Takeda has a chance of breaking into new territory with its blood cancer therapy Iclusig, after the drug performed better than mainstay therapy imatinib in a phase 3 study of adults with newly-diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).

FDA approves first drug to delay type 1 diabetes

European Pharmaceutical Review

Tzield (teplizumab-mzwv), the first drug to help prolong the onset of stage 3 type 1 diabetes in adults and children over eight years old with stage 2 type 1 diabetes, has been approved by the US Food and Drug Administration (FDA).

After disappointing trial, Editas puts lead CRISPR drug up for sale

Pharma Phorum

Gene-testing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial.

Leads 79

Advanced Biodesign starts first-in-human clinical trial targeting AML

European Pharmaceutical Review

Advanced BioDesign , a French biotechnology company specialising in the development of targeted therapies in oncology, announced that the first patient has been treated, at the Centre d’Investigation des Thérapeutiques en Oncologie et Hematologie de Lyon (CITHOL), with its first-in-class drug candidate: ABD-3001 for acute myeloid leukaemia. .

Automation in Biopharma and the Impact on Workflows

PharmaTech

Webinar Date/Time: Wednesday, November 30, 2022 at 11 am ET | 10 am CT | 8 am PT.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Pharma Leaders

As per the terms of the agreement, Tenacia will get sole rights to develop and commercialise some formulations of ganaxolone in Mainland China, Hong Kong, Macau and Taiwan, The post Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology appeared first on Pharmaceutical Business review. Industry News

MilliporeSigma Commits $286 Million toward US Biosafety Testing

Pharmaceutical Commerce

Drug safety analysis to be conducted at Rockland, MD facility.

Do More with Less: Making the Most of Your Marketing Budget

LEVO Health

Marketing teams in the medical industry have been asked to do more with less due to shrinking marketing budgets. As healthcare executives slash media spending ahead of an anticipated recession, medical practices and their marketing teams need to be more creative in their advertising strategies.

First COVID-19 impact report on global vaccine markets

European Pharmaceutical Review

The World Health Organization (WHO)’s Global Vaccine Market Report 2022 , the first report to examine the impact of COVID-19 on the global vaccine market, shows that inequitable distribution is not unique to COVID-19 vaccines, with poorer countries consistently fighting to access vaccines in demand by wealthier countries.

FDA Approves Teplizumab-mzwv, the First Drug to Delay Onset of Type 1 Diabetes

Pharmacy Times

Teplizumab-mzwv is administered through injection and can delay the onset of type 1 diabetes in adults and pediatric patients.

TRANSFORMATIVE INNOVATION

PharmaTech

ADVANCING DRUG DEVELOPMENT USING IN SILICO MODELING.

40

Student Pharmacists Can Play Important Role as Patient Advocates

Pharmacy Times

Education and support inspire trust between patients and pharmacists.

4 TIME-SAVING SOLUTIONS TO COMMON EARLY DEVELOPMENT CHALLENGES

PharmaTech

In the race to market, you need fast, cost-effective, and scientifically proven solutions to seamlessly guide your molecule through early-phase development. Explore these five flexible solutions that enable you to move your molecule through each early development phase with efficiency and speed.